Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Q2 2026 vs. Q1 2026
How the institutions holding Carisma Therapeutics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 3 | 1 | −2 |
| Shares | 1.47M | 785 | −1.47M (−99.9%) |
| Value | $47.9K | $4 | −$47.9K (−100.0%) |
New holders (0)
Institutions that held Carisma Therapeutics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (2)
Institutions that held Carisma Therapeutics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Merck & Co., Inc. | 1,473,240 | $47.9K |
| Golden State Equity Partners | 200 | $6 |